Reactive oxygen species (ROS). Chemically reactive molecules containing oxygen that, when produced in large amounts, have pro-inflammatory and antimicrobial effects. Physiological levels of ROS have been shown to regulate cellular signalling pathways.
Neutrophil migration in infection and wound repair: going forward in reverse Abstract | Neutrophil migration and its role during inflammation has been the focus of increased interest in the past decade. Advances in live imaging and the use of new model systems have helped to uncover the behaviour of neutrophils in injured and infected tissues. Although neutrophils were considered to be short-lived effector cells that undergo apoptosis in damaged tissues, recent evidence suggests that neutrophil behaviour is more complex and, in some settings, neutrophils might leave sites of tissue injury and migrate back into the vasculature. The role of reverse migration and its contribution to resolution of inflammation remains unclear. In this Review, we discuss the different cues within tissues that mediate neutrophil forward and reverse migration in response to injury or infection and the implications of these mechanisms to human disease.
. The exact signals that control this early stage in mice are mostly unknown but they are probably sensed by GPCRs, as treatment of neutrophils with pertussis toxin, which inhibits GPCR-Gα i signalling, limits this early chemotaxis towards the damage site 7 . The signals promoting the early recruitment of neutrophils have been investigated in more detail in larval zebrafish, as this model is amenable to live imaging of early neutrophil recruitment after tissue damage
.
In larval zebrafish, one of the main early signals known to be directly sensed by neutrophils after wounding and to promote early forward migration is H 2 O 2 . After a tail wound in zebrafish up to a 200 μm radial gradient of H 2 O 2 is formed, beginning only three minutes after wounding, with levels peaking at 20 minutes post wounding 18 . A H 2 O 2 gradient is also observed in wounded Drosophila melanogaster embryos 19 . This early H 2 O 2 gradient is primarily produced by the enzyme dual oxidase 1 (DUOX1) in epithelial cells, and depletion of this enzyme in either zebrafish or D. melanogaster inhibits neutrophil migration to a wound 18, 19 . Importantly, H 2 O 2 also promotes chemotaxis of human 20 and mouse 21 neutrophils in vitro. SRC family kinases (SFKs) directly sense this H 2 O 2 gradient and are required in zebrafish for early neutrophil recruitment to wounds and in human neutrophils for chemotaxis to H 2 O 2 in vitro 20 . Upon H 2 O 2 exposure, a specific cysteine residue in the zebrafish SFK LYN is oxidized, promoting the autophosphorylation and activation of LYN, and this activates multiple downstream pathways including ERK signalling 20 . The exact mechanism by which LYN directs the migration of neutrophils towards the source of H 2 O 2 is unknown, but it is likely that the signalling pathway converges on the activation of PI3K, RAC and ERK to mediate directed migration (BOX 2) . H 2 O 2 -LYN signalling seems to be important only for early neutrophil recruitment in zebrafish 20 . Moreover, neutrophils from mice deficient in three SFKs that were transplanted into a wild-type animal were still able to infiltrate to a site of inflammation, although mice deficient in these SFKs are protected from autoantibody-induced arthritis because SFKs are necessary for the inflammatory microenvironment 22 . The many DAMPs that are released from damaged and necrotic cells also function to directly modulate neutro phils. For example, ATP can be sensed by two different classes of receptors, P2Ys (which are GPCRs) or P2Xs (which are ligand-gated ion channels) 23 . Zebrafish treated with apyrase or inhibitors of P2Y and P2X signalling have fewer neutrophils recruited to a wound 24 . Although ATP can directly induce monocyte and macrophage migration in vitro through the activation of P2Y purinoceptor 2 (P2Y 2 ) 25 , it is unclear if ATP directly activates chemotaxis of neutrophils. It has been shown that neutrophil-released ATP can function as an autocrine signal at the leading edge of the cell to amplify chemo tactic signals through P2Y 2 receptors and increase the efficiency of chemotaxis 26 . The autocrine effects of ATP and its metabolite adenosine at the cell front and rear of neutrophils, through the P2Y 2 receptor and the A 2a receptor, respectively, promote efficient chemotaxis through differential effects on mechanistic target of rapamycin (mTOR) 94, [143] [144] [145] . Recent studies using microfluidics have highlighted mechanisms that differentially regulate neutrophil migration in two-dimensional compared with three-dimensional environments 146 . These in vitro studies are complemented by more recent work that images neutrophil migration within the tissue microenvironment in zebrafish and mice. Intravital imaging in mouse models has been developed to directly visualize and measure neutrophil migration and function in specific organs after acute tissue damage. These models mainly focus on peripheral tissues in mice that are amenable to imaging, including the cornea 147 , ear dermis 7, 68 and cremaster muscle 110, [148] [149] [150] . Other methods create 'windows' through which immune cell infiltration can be visualized in the brain 151 and the lungs 152 . Neutrophil recruitment to the liver has been studied for many years by externalizing it to allow for high-resolution intravital imaging 33, 153, 154 . Nevertheless, these models are invasive, often requiring animal sacrifice shortly after the experiment and are generally not amenable to long-term studies. In addition, these models do not provide high temporal and spatial resolution, making it difficult to analyse behaviours of early-recruited neutrophils.
Zebrafish have been increasingly used for the study of innate immune cell function, including neutrophil migration [155] [156] [157] . Transparent larvae allow in vivo imaging of neutrophil migration in the context of a whole living organism on the scale of days. Zebrafish neutrophils have similar morphology, behaviour and function to mammalian neutrophils 158, 159 , and zebrafish have been successfully used to model human neutrophil disorders 155, 156 . With fluorescent tags, specific cells and subcellular structures can be visualized, and the use of tracking software enables researchers to easily measure multiple parameters of neutrophil motility, including speed and directionality, early after tissue damage. In fact, neutrophil reverse migration was first visualized in zebrafish 101 , and zebrafish are currently being used to elucidate the mechanisms controlling reverse migration 108 . Zebrafish larvae are ideal for screening chemical compounds -with such screens a fungal-derived compound that inhibits neutrophil chemotaxis 160 and a compound that promotes the resolution of neutrophil-mediated inflammation 107 were recently discovered. . There is also evidence that the presence of ATP can enhance the migration of neutrophils towards N-formyl peptides or CXC-chemokine ligand 8 (CXCL8) by activating RHOA 28, 29 . Early neutrophil chemotaxis and activation is also triggered by N-formyl peptides, such as fMet-Leu-Phe (fMLP). Although these peptides can be derived from bacterial proteins, they are also released from mitochondria after tissue damage and activate human neutrophils by binding to the GPCRs fMLP receptor 1 (FPR1), FPR2 and FPR3 . In vitro, FPR1-specific antibodies block neutrophil migration to disrupted mitochondrial products 31 or necrotic cells 33 . FPR1 blockade or deficiency also prevents the guidance of recruited neutrophils to necrotic cells in a localized hepatic injury in mice 33 , which highlights the importance of this signal as a short-range cue for proper neutrophil localization to a site of injury.
Other early signals produced by tissue and tissueresident cells. The initial signals can be short-lived; studies in zebrafish suggest that the peak of H 2 O 2 production is around 30 minutes after injury and the signal is completely cleared 1 hour later by the myeloperoxidase activity of wound-associated neutrophils 34 . For more sustained neutrophil recruitment, long-term and long-range signals are activated, mainly comprising chemokines and lipid mediators. The CXCL8 family comprises some of the main chemokines that are involved in neutrophil migration, including CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7 and CXCL8. These chemokines are sensed by neutrophils through the GPCRs CXC-chemokine receptor 1 (CXCR1) and CXCR2 (REFS 35, 36) and activate downstream signalling to vasodilator-stimulated phosphoprotein (VASP), PI3K and SFKs to mediate neutrophil directed migration 37, 38 
. These chemokines can be produced by both immune cells (including neutrophils, macrophages and T cells) and non-leukocytes (including epithelial and endothelial cells) in response to both injury and infection. Human CXCL8 has been known to be a neutrophil chemoattractant for more than 25 years 39 , and the role of CXCL8 family-CXCR signalling in neutrophil migration has been confirmed in vivo in both mice and zebrafish [40] [41] [42] [43] [44] . To attract more distant neutrophils, CXCL8 family chemokines, among other chemokines, can bind to glycosaminoglycans on cell walls and in the extracellular matrix to create chemokine gradients along the tissues and structures through which neutrophils migrate 33, 42, 45 . When HEK293T cells expressing fluorescently tagged CXCL8 were transplanted into zebrafish larvae, the CXCL8 accumulated locally around the transplanted cells but then spread outwards into the vasculature, forming immobilized gradients 42 . Such intravascular extracellular matrix-bound chemokine gradients have also been observed in mouse models of acute hepatic injury, reaching as far away as 650 μm 33 , and when CXCL8 was injected intradermally into rabbits or added to human skin ex vivo it appeared to be bound to the lumen of venular endothelial cells 46 . Lipid mediators are also strong inducers of neutro phil chemotaxis. These mediators are derived from arachidonic acid. After arachidonic acid release by activated cytosolic phospholipase A 2 (cPLA 2 ), arachidonic acid is metabolized through multiple enzymatic pathways into a wide range of molecules, each with specific functions. The lipid mediator that is known to have the largest effect on neutrophil migration is leukotriene B 4 (LTB 4 ), which is produced from arachidonic acid by 5-lipoxygenase and sensed by the GPCR BLT 1 receptor (also known as LTB 4 R) to induce neutrophil polarization and migration
. Although some LTB 4 is produced fairly early after wounding to recruit neutrophils, it also functions in the amplification stage of neutrophil recruitment and is discussed in detail in the next section. Other lipid mediators can also induce neutrophil chemotaxis, including 5-oxo-eicosatetraenoic acid (5-KETE) 47 . In most cases, the production of these chemo kines and lipid mediators is activated by DAMPs that are released after cell damage. Pre-made stores of chemo kines can be rapidly released via exocytosis from endothelial cells that are activated by DAMPs 48, 49 . DAMPs also activate core enzymatic and transcriptional pathways, such as nuclear factor-κB (NF-κB) and activator protein 1 (AP-1), which result in the production of chemokines and lipid mediators. Recently, in two different mouse models, DAMPmediated activation of the NLRP3 (NOD-, LRR-and pyrin domain-containing 3) inflammasome by ATP was linked to persistent neutrophil recruitment 33, 50 .
Box 2 | Neutrophil signalling in motility
There is an extensive literature on the downstream signalling mechanisms that regulate neutrophil directed migration to specific chemokines and other signals 6, 11, [161] [162] [163] [164] , and only general principles are discussed in this Review. Directed migration is mediated by chemoattractant signalling through G protein-coupled receptors (GPCRs) and other receptors that induce the asymmetric localization and activation of key signalling molecules, including phosphoinositide 3-kinase (PI3K), phospholipase C (PLC) and members of the RHO GTPase family, such as RAC 165 (see the figure) . The asymmetric distribution of the PI3K product phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 ) at the front of polarized neutrophils is a hallmark of gradient sensing induced by chemoattractants [165] [166] [167] . The localized recruitment of PtdIns(3,4,5)P 3 mediates the recruitment of specific adaptor proteins and guanine nucleotide-exchange factors, such as dedicator of cytokinesis protein 2 (DOCK2) and PtdIns(3,4,5)P 3 -dependent RAC exchanger protein 1 (PREX1), respectively, that lead to the activation of RAC signalling and polarized actin polymerization during directed migration 168, 169 . Although many attractant cues signal through PI3K and RAC, there is evidence that signalling hierarchies exist in which some chemoattractants are more dependent on p38 mitogen-activated protein kinase or PI3K signalling in vitro 170 . Specificity can be provided by the interaction of chemokine receptors with different ligands or the binding of receptors to specific downstream binding partners as has been described with the binding of CXC-chemokine receptor 2 (CXCR2) to vasodilator-stimulated phosphoprotein (VASP) 38 . In addition, different GPCR kinases have been reported to bind to CXCR1 and CXCR2, providing specificity in the regulation of receptor internalization and therefore an additional layer of regulation 171 .
Less is known about the key signals that mediate neutrophil migration in vivo.
Zebrafish are an important tool for the analysis of signalling in vivo, and recent studies have showed that both RAC signalling 172 and calcium flux 173 at the leading edge are sufficient to guide cell movement in live animals. However, despite recent progress, a challenge for future investigation remains in determining how neutrophils prioritize competing cues in vivo through the modulation of specific downstream intracellular signalling pathways that mediate responses to tissue damage. 
RAC1 RAP1
Pathogen-associated molecular patterns (PAMPs) . Molecules that are derived from pathogens such as bacteria, fungi or viruses. They readily diffuse through tissues and can be protein-derived or non-protein-derived.
Tissue injury also results in the release of intracellular ion stores, creating alterations in neighbouring cell osmolarity. In vivo in zebrafish larvae, cells surrounding tissue wounds can sense changes in osmolarity through the activation of cPLA 2 and the release of arachidonic acid, which is metabolized into 5-KETE 51 . Knockdown of expression of cPLA 2 or oxo eicosanoid receptor 1 (OXER1; the GPCR for 5-KETE) inhibited leukocyte recruitment to a wound by decreasing both neutrophil velocity and directionality 51 .
Amplification of neutrophil recruitment. Neutrophil recruitment is exponentially amplified in a phase sometimes termed 'neutrophil swarming' . To promote this phase, more signals must arise from the early-recruited cells -including neutrophils and macrophages -to recruit more neutrophils both directly and indirectly through the further activation of tissue and tissueresident cells 8, 52 . This is the next step in the cascade of signals that promotes neutrophil forward migration and involves many of the same signals that are involved in earlier phases, including LTB 4 and CXCL8 family chemokines 7, 52 . LTB 4 can amplify neutrophil responses to primary chemoattractants in several ways. In vitro, in response to fMLP, human neutrophils generate local microgradients of LTB 4 at their leading edge, functioning as an autocrine signal and stabilizing neutrophil polarization 53 . Longer range gradients of LTB 4 are also created to recruit new neutrophils 53 . In a mouse model of laser-induced dermal tissue injury, LTB 4 R-deficient neutrophils close to a wound were able to undergo chemotaxis to the wound, but more distant neutrophils required LTB 4 R to be efficiently recruited, which suggests that LTB 4 is specifically required for persistent and long-term neutrophil infiltration 54 . This defect in recruitment is similar to that observed when all GPCR-Gα i2 signalling is inhibited 54 , providing evidence that LTB 4 is a major signal in this phase. In addition to the requirement for sensing LTB 4 through its receptor, neutrophils are also a source of LTB 4 and neutrophils that genetically lacked 5-lipoxygenase also could not swarm to the wound 54 . LTB 4 production is also important for neutrophil recruitment in mouse models of inflammatory arthritis 55, 56 . Furthermore, the amplification step is likely to be initiated through the recognition of DAMPs by the early-recruited cells. In addition to functioning as direct neutrophil chemoattractants, N-formyl peptides activate ERK1, ERK2 and p38 mitogen-activated protein kinase signalling pathways 57 and stimulate LTB 4 production by neutrophils 53 . Cyclic ADP ribose (cADPR; a metabolite of NAD + ) has also been shown to have a role in this amplification stage in a mouse model of laser-induced dermal tissue injury 7 . Treatment of neutrophils with a competitive inhibitor of cADPR signalling did not affect early neutrophil recruitment but prevented the amplification phase of the neutrophil response 7 . In a mouse model, neutrophil swarming correlated with cell death of some of the initially recruited cells and this probably produces more DAMPs 54 . The exact signals that these dying cells release to induce swarming is unclear because neutrophils deficient in single GPCRs including Fpr1, Fpr2, Cxcr2 and P2rx7 could migrate short distances normally when injected into the damaged tissue in this model 54 , and it is likely that a combination of signals is released.
Other secondary signals are also produced by these early-recruited neutrophils. In a model of inflammatory arthritis, LTB 4 -activated neutrophils produce chemokines, such as CXCL2, and the cytokine interleukin-1β (IL-1β), which activates tissue endothelial cells, fibroblast-like cells and macrophages to produce more ligands for CXCR1, CXCR2 and CC-chemokine receptor 1 (CCR1), further amplifying neutrophil recruitment 58 . Activated neutrophils also express matrix metalloproteinases (MMPs), which can cleave CXCL8 family chemokines to increase their chemotactic effect 59, 60 . Collagen in the extracellular matrix can also be cleaved by neutrophil MMP activity to create collagen-derived chemotactic peptides 61 . In addition to early-recruited neutrophils, recruited monocytes and macrophages amplify the neutrophil response. Pro-inflammatory monocytes and macrophages can be recruited by initial DAMP signals but neutro phils also recruit these cells through the production of macrophage chemokines and through further activation of surrounding non-immune tissue cells, setting off a feed-forward loop of neutrophil recruitment 62 .
Additional levels of signalling in infection.
The tight control of neutrophil recruitment after infection is arguably even more important than after tissue injury. Although inflammation must be maintained until the infection is cleared, neutrophils can also provide niches within which pathogens can replicate 63 . Neutrophil swarms have been observed after infection with several types of pathogen, including bacteria 64 and protozoa 65 . Neutrophil infiltration in response to early-recruited neutrophil cell death 54 is likely to be even more pronounced in infections, as many pathogens can cause necrosis of host cells 66 . Neutrophil recruitment can also be altered by pathogens that carry virulence factors that directly interfere with or promote neutrophil recruitment [67] [68] [69] . Probably one of the most important differences in infections is the presence of pathogen-associated molecular patterns (PAMPs) in addition to tissue DAMPs, which creates an extra level of danger signals (reviewed in REF. 70 ). Another major variable in infection is the duration of the damage, especially if the pathogen is not cleared. These factors lead to a much wider range of immune cells participating in and modulating neutrophil recruitment, including macrophages 68, 71 , dendritic cells 72 , mast cells 73 and T cells 74 . As in a sterile tissue injury, tissue and tissue-resident cells can sense the presence of infection-induced damage and can transmit signals to neutrophils through the production of chemokines. Perivascular macrophages produce CXCL1 and CXCL2 to promote neutrophil extravasation at sites of bacterial infection in mouse ear skin 68 , whereas dendritic cells produce CXCL1 and CXCL2 after an infection with Leishmania spp. 72 . Mast cells can indirectly recruit neutrophils to a site of infection through the production of tumour necrosis factor (TNF) 75 or a tryptase 76 , both of which promote chemokine production from tissue cells. Mast cells also directly recruit neutrophils through the production of leukotrienes such as LTB 4 and LTC 4 (REF. 77 ).
The same amplification of neutrophil recruitment through feed-forward signalling and macrophageneutrophil-tissue cell crosstalk is also observed after infection. In a mouse model of uropathogenic Escherichia coli infection, tissue-resident macrophages (denoted lymphocyte antigen 6C (LY6C) low ) first sense the infection and produce a variety of chemokines, of which CXCL1 is the most important, to recruit both neutrophils and nonresident inflammatory macrophages (denoted LY6C hi ) 71 . These inflammatory macrophages then produce TNF to further activate the tissue-resident macrophages to release pre-formed stores of CXCL2 that further recruit neutrophils to the infection site 71 . In Staphylococcus aureus infection, early-recruited immune cells phagocytose the bacteria, leading to inflammasome activation by the bacterial cell wall component peptidoglycan and to IL-1β secretion 78, 79 . IL-1β then activates non-immune tissue cells to produce more pro-inflammatory cytokines and neutrophil chemokines 80 . The adaptive immune system has a key role in the persistent neutrophil inflammation that can be induced by infection. In several models, T cells and T cellproduced cytokines are important for neutrophil recruitment to infection, including Streptococcus pneumonia 81 and Helicobacter pylori 82 infections. Many factors contribute to the crosstalk between T cells and neutrophils in the context of infection 83 , but the involvement of the cytokine IL-17 seems to be particularly important 84, 85 . In a cutaneous model of S. aureus infection, resistance to infection depends on the presence of neutrophils 86 , and both αβ T cells and IL-17-producing T cells have been shown to be important for the neutrophil response 74 . IL-17 stimulates both tissue cells and leukocytes to produce a range of cytokines, including CXCL8 family chemokines and granulocyte-colony stimulating factor (G-CSF), which promotes the production and the maturation of neutrophils from the bone marrow 87, 88 . After infection with S. aureus, mice with lowered IL-17 levels as a result of γδ T cell deficiency had lowered levels of CXCL1 and CXCL2 production and consequently impaired neutrophil recruitment 89 . In this case, decreased neutrophil recruitment resulted in poor infection outcome, which could be rescued by administration of recombinant IL-17 (REF. 89 ).
Distinguishing an infection from a wound. It is crucial for the host to distinguish whether a tissue injury has an associated infection, as this determines both the strength and the length of the appropriate response. Responses to infection, such as an S. aureus skin infection, can create especially large neutrophil swarms 90 . Exactly how the host integrates information on the persistence of damage and the diversity of signals after wounding or infection into differing responses is not clear. This question is relevant for the development of anti-inflammatory therapies that prevent chronic inflammation but that retain a sufficient response to infection. Although many DAMPs and PAMPs signal through similar receptors and converge on similar signalling pathways, there is evidence that cells can interpret and respond to these signals differently 91 . A few studies have directly compared the requirements for neutrophil recruitment to a wound versus an infection. In zebrafish larvae, H 2 O 2 was found to be required for the early neutrophil response to a wound but not to Pseudomonas aeruginosa or Streptococcus iniae infections 92 . Moreover, IL-1β and myeloid differentiation primary response protein 88 (MYD88)-mediated signalling were required for neutrophil responses to a wound but not to E. coli infection 93 . There is also evidence that neutrophils migrate differently to host-produced versus pathogen-produced signals. In vitro, human neutrophils retrotaxed after responding to a gradient of LTB 4 , whereas the neutrophils were 'trapped' after they arrived at a source of the fungal cell wall component zymosan 94 .
One mechanism for the distinction between a wound and an infection involves CD24 and its ability to specifically trap DAMPs (including HMGB1, heat shock protein 70 kDa (HSP70) and HSP90) and prevent their binding to receptors 95, 96 . CD24 interacts with Siglec-G, which associates with SH2 domain-containing protein tyrosine phosphatase 1 (SHP1; also known as PTPN6), a negative regulator of NF-κB activation 97 . In this manner, CD24 decreases NF-κB-mediated activation of tissue-resident cells such as dendritic cells and thereby reduces the amplification stage of neutrophil recruitment 97 . It has been proposed that neutrophils have phenotypic heterogeneity and functional plasticity
; several markers of different neutrophil phenotypes have been identified, although disease associations and functional characteristics of these phenotypes need to be established 98 . Differing signals at a wound or infection probably define the phenotype of the responding neutrophils (either by altering their phenotype after they arrive at the site or by specifically recruiting certain subsets that pre-exist in the circulation). A future challenge will be to determine the distinct neutrophil subsets that exist in different types of damage, including 'sterile' versus infected tissue, and to probe the complex signalling networks that integrate diverse inputs into a specific response.
Reverse migration of neutrophils
In a successful response to an acute injury, it is crucial to prevent tissue damage by promoting the local resolution of inflammation through the removal of neutrophils from the site of injury 62 . This clearance of neutrophils can occur through apoptosis or necrosis and subsequent phagocytosis by macrophages 99 . However, some early evidence suggested that neutrophils at inflamed sites do not necessarily undergo apoptosis. Hughes and colleagues used a rat model of glomerular capillary injury to track the fate of radiolabelled neutrophils and found that ≥70% of neutrophils that entered inflamed glomerular capillaries were able to return to the main circulation and did not undergo apoptosis at the site of . More recent studies have showed that neutrophils can leave sites of tissue damage in a process termed neutrophil reverse migration, which describes the interstitial migration of neutrophils away from inflamed sites. Neutrophils have also been reported to re-enter the vasculature in a distinct process referred to as neutrophil reverse transendothelial migration (rTEM).
Neutrophil reverse migration within tissues away from the site of injury was first directly visualized in vivo in zebrafish larvae, in which it was shown that not all recruited neutrophils die at the site of injury, and most leave the site 101 . In subsequent studies using zebrafish, it was shown that neutrophils that leave a wound can undergo rTEM and traffic to distal sites post injury 102, 103 . Moreover, Buckley and colleagues 104 described the ability of human neutrophils to reverse transmigrate through an endothelial monolayer in vitro, identifying markers that are characteristic of these reverse-transmigrated neutrophils (intercellular adhesion molecule 1 (ICAM1) hi CXCR1 low ), and found this neutrophil phenotype in the peripheral blood of patients with systemic inflammation. Since these early studies, neutrophil reverse migration and/or rTEM have been visualized in multiple models including zebrafish [105] [106] [107] [108] , mice 109, 110 and in vitro using human neutrophils 94, 111 (FIG. 2) . In vitro studies using microfluidics showed that more than 90% of human neutrophils can reverse their direction away from a chemoattractant and migrate away continually for distances greater than 1,000 μm 111 . Together, these studies have suggested that reverse migration is a possible mechanism to locally resolve inflammation and is a potential novel target for drug therapy in diseases charac terized by excessive neutrophil infiltration. However, a caveat is that neutrophil reverse migration may lead to activated neutrophils being redistributed to other locations in the body, contributing to inflammation elsewhere. It is also important to note that many aspects of neutrophil reverse migration remain controversial including the exact mechanism(s), the fate of reverse-migrated neutrophils and the occurrence of reverse migration in human disease.
Potential mechanisms of reverse migration. The cues that mediate neutrophil reverse migration from sites of tissue damage remain mostly unknown. Reverse migration can be confused with the terms fugetaxis or retrotaxis 112 , mechanisms that may have only a partial role in neutrophil reverse migration in vivo. Several mech anisms have been proposed to explain the reverse migration of neutrophils from inflamed tissues, including a competition between chemoattractant sources at the wound and the vasculature. A neutrophil may prioritize competing cues through the downregulation of specific chemokine receptors and/or receptor desensitization. It has also been postulated that new chemo repellent cues may be released at the wound to mediate neutrophil reverse movement. Finally, other factors may influence the potential to leave damaged tissues, including decreased levels of wound chemoattractants and/or neutrophil-intrinsic transcriptional changes 113 . Neutrophils constantly sense a variety of stimuli and must process and prioritize all of these inputs to determine their behaviour and it is likely that a process as complex as reverse migration occurs through a combination of these mechanisms.
Few studies have shown a direct link between neutrophil reverse migration and specific pathways (FIG. 2) . However, one pathway that has been specifically implicated in neutrophil migration out of wounded tissue in larval zebrafish is the hypoxia-inducible factor 1α (HIF1α) pathway 105 . In addition to reducing neutrophil apoptosis, HIF1α activation in zebrafish neutrophils
Box 3 | Neutrophil heterogeneity and plasticity
During the past decade, evidence has been accumulating for the existence of neutrophil subsets with phenotypic heterogeneity and functional plasticity in different models 106, 174, 175 . Perhaps the best characterized example is in the tumour microenvironment, in which neutrophils develop polarity that is similar to the M1 and M2 polarization described for macrophages. Tumour-associated neutrophils can be designated as N1 (anti-tumorigenic and pro-inflammatory) and N2 (pro-tumorigenic and immunosuppressive) 176 . Tumour-associated N2 neutrophils are characterized by high expression of CXC-chemokine receptor 4 (CXCR4), vascular endothelial growth factor and matrix metalloproteinase 9 and are induced in the presence of high levels of transforming growth factor-β (TGFβ). By contrast, N1 neutrophils express pro-inflammatory cytokines and chemokines, can kill cancer cells and are induced by inhibition of TGFβ signalling. Analogous neutrophil subsets may exist in damaged or infected tissues, although these phenotypes have not been well characterized. Subsets of neutrophils have also been defined by surface receptor expression and density (low-density neutrophils versus high-or normal-density neutrophils). For example, CXCR4 expression is increased in aged or senescent neutrophils 177 and is associated with neutrophil trafficking to the bone marrow. Other changes in the expression of surface proteins on neutrophils have been described, including CD63 expression in the airways of patients with cystic fibrosis 178 , intercellular adhesion molecule 1 (ICAM1) expression associated with systemic inflammation and reverse migration 120 or CD177 expression associated with autoimmune diseases 174, 179 . Low-density neutrophils have been associated mostly with autoimmune disorders 180 , sepsis 181 , HIV infection 182, 183 and cancer 176 . In addition to heterogeneity, neutrophil phenotypes can be plastic. For example, neutrophils under specific inflammatory settings have been reported to differentiate into other myeloid cell types 83 , including dendritic cells (DCs), and purified bone marrow-derived neutrophils can differentiate into a hybrid population characterized by the expression of DC and neutrophil markers after in vitro treatment with granulocyte-macrophage colony-stimulating factor, tumour necrosis factor and interleukin-4, and this has been verified both in vitro and in vivo 184 . It is likely that the environment (pro-or anti-inflammatory as well as the tissue or organ microenvironment) helps to control neutrophil differentiation and modulate the specialization and function of these cells. Figure 2 | Mechanisms that may be involved in neutrophil reverse migration. Several models for reverse migration have been developed: in vitro microfluidic assays or transwell assays (part A), larval zebrafish wounding (part B) and mouse ischaemia-reperfusion injury to model reverse transendothelial migration (rTEM; part C). These studies have reported mechanisms that regulate both neutrophil reverse migration in interstitial tissues and rTEM. A | Chemoattractants, such as CXC-chemokine ligand 8 (CXCL8), can function as chemorepellents at high concentrations in vitro, referred to as fugetaxis (part a). Reverse neutrophil transmigration through endothelial cell monolayers has been reported; reverse-transmigrated neutrophils are characterized by high expression of intercellular adhesion molecule 1 (ICAM1) and low expression of CXC-chemokine receptor 1 (CXCR1) (part b) . In vitro analysis in microfluidics has identified factors that regulate neutrophil forward and reverse migration (part c). The pro-resolving lipid mediator lipoxin A 4 (LXA 4 ) induces neutrophil reverse migration whereas zymosan induces neutrophil trapping. B | The reverse migration and rTEM of neutrophils has been visualized in larval zebrafish tail wounds using photoconversion (part a). The activation of hypoxia-inducible factor 1α (HIF1α) in zebrafish neutrophils inhibits neutrophil reverse migration (part b), whereas the migration of macrophages to the wound via reactive oxygen species (ROS)-SRC family kinase (SFK) signalling and their direct interaction with neutrophils promotes neutrophil reverse migration (part c). C | A mouse ischaemia-reperfusion injury model is used to model neutrophil rTEM or 'hesitant' TEM. In this model, junctional adhesion molecule C (JAMC) on endothelial cells modulates 'complete' TEM and leukotriene B 4 (LTB 4 ) induces neutrophil elastase expression, which cleaves JAMC, leading to an increase in rTEM 119 (part a). Increased rTEM in this model leads to higher numbers of neutrophils with rTEM markers (ICAM1 . It is known that in vitro chemoattractants such as CXCL8 can function as chemorepellents in higher concentrations 114 and therefore neutrophil behaviour might change as the cell migrates up a chemokine gradient. Data indicating that reverse-migrated human neutro phils have lowered cell surface expression of CXCR1 (REF. 104 ) provides some evidence for the idea that neutrophils might stop responding to chemoattractants at the wound because of receptor internalization or downregulation. Other tissue-resident cells are also implicated in the control of neutrophil reverse migration. In zebrafish, direct contact of neutrophils with macrophages at a wound induces neutrophils to migrate away and autocrine redox-SFK signalling in macrophages is required for the resolution of neutrophil inflammation 108 . This is an especially intriguing observation in the context of patients with chronic granulomatous disease (CGD) and deficient ROS signalling who develop chronic neutrophil inflammation in tissues 115 . The relative levels of different lipid mediators can also promote the resolution of inflammation and may be involved in neutrophil reverse migration. As discussed, LTB 4 is a neutrophil chemoattractant but, after lipidmediator class switching, pro-inflammatory lipid mediator production pathways are altered to instead produce pro-resolution mediators such as lipoxin A 4 (LXA 4 ) 116, 117 . Other pro-resolution lipid mediators include resolvins and protectins and stop the influx of new neutrophils 118 . They are also implicated in promoting the resolution of existing neutrophil inflammation: LXA 4 can enhance the reverse migration of human neutrophils in vitro in a microfluidic device 111 . In addition to reverse migrating through tissue away from an injury, neutrophils may also re-enter the circulation through rTEM. Neutrophils that were recruited to a tissue wound could be observed back in the circulation in zebrafish 102, 103 . In mice, in which there are greater challenges to imaging than in zebrafish, the Nourshargh laboratory has used 'disturbed' neutrophil TEM after ischaemia-reperfusion injury as a model for rTEM 110, 119 . In this model, junctional adhesion molecule C (JAMC) at endothelial cell junctions modulates 'complete' TEM and a decrease in the levels of JAMC expression after injury increases the occurrence of rTEM 110 . Moreover, LTB 4 stimulates the production of neutrophil elastase, which cleaves JAMC and therefore increases rates of rTEM 119 . This suggests that LTB 4 may be involved in both forward and reverse transmigration to damaged tissue.
What determines whether neutrophils reverse migrate or die at the site of damage? Different neutrophil subsets might be predisposed to reverse migrate from the time they leave the circulation or because of transcriptional changes induced at the injury site 98, 120 
In vitro, neutrophils that encounter the fungal cell wall component zymosan have decreased reverse migration 94, 111 , and it is tempting to speculate that neutrophils are less likely to reverse migrate away from sites of infection, at least partly to prevent the dissemination of intracellular pathogens.
It has been proposed that neutrophils do not actively undergo directed reverse migration, but they are simply randomly redistributed away from the wound. By simulating neutrophil behaviour with different mathematical models on the basis of neutrophil migration measurements made in zebrafish, several studies suggested that the migration of neutrophils away from a wound could be best described by a diffusion process rather than by a fuge taxis process 107, 121, 122 . Therefore reverse migration of neutrophils might be a result of a loss of sensitivity towards recruitment and/or retention signals rather than active repulsion induced by the release of a chemorepellent from the wound or by active attraction as a result of chemoattractants in the blood or vascular endothelial cells. Overall, the mechanisms controlling reverse migration are still not clear. It is likely that multiple processes contribute to the migration of neutrophils away from a site of inflammation and back into the circulation, possibly combined in a reverse migration cascade.
What is the phenotype and fate of reverse-migrated neutrophils? Do reverse-migrated neutrophils have a different phenotype compared with 'naive' neutrophils? Neutrophils in peripheral tissues are known to be more active transcriptionally and translationally than their counterparts in the circulation 123 . Neutrophils that have undergone rTEM in vitro were found to express specific markers, ICAM1 hi and CXCR1 low (REFS 104,110), and these markers have been used to identify neutrophils that had presumably undergone rTEM in peripheral human blood 104 and in secondary sites of inflammation in mice 110 . In addition, human neutrophils that have undergone rTEM in vitro are less susceptible to apoptosis and produce more ROS 104 , and mouse neutrophils expressing rTEM markers in vivo also produce higher levels of ROS
110
. By contrast, although zebrafish reverse-migrated neutrophils (not necessarily neutrophils that underwent rTEM) were found to have an activated morphology, they did not have altered ROS production or response to a secondary insult, whether a tissue wound or an infection 106 . There is no clear evidence, therefore, that all reversemigrated neutrophils show a pro-or anti-inflammatory phenotype. These neutrophils may in fact have varying fates or phenotypes according to where and how they are recruited out of the blood into tissues in the first place and what they encounter at the injury site.
Where do neutrophils go after reverse migrating out of the tissue? Zebrafish neutrophils can be found in tissues or in the circulation for at least 2 days after leaving a wound 102 . The fate of these neutrophils is important for patients, as systemic inflammation after severe trauma can lead to multiple organ failure 124 . Recently, human patients with acute pancreatitis that developed acute lung injury were found to have a higher level of neutrophils carrying rTEM markers in their circulation 125 . In a mouse model of acute pancreatitis, increasing the level of neutrophils expressing rTEM markers in the circulation and pulmonary vasculature through genetic deletion of JAMC increased the severity of lung injury and systemic inflammation 125 . Similarly, after ischaemia-reperfusion injury in mice, neutrophils with rTEM markers were found to be relocalized in the lungs 110 . Furthermore, experimentally increasing the rates of rTEM resulted in increased neutrophil relocalization and organ damage in the lungs, liver and heart 119 . Neutrophils have also been shown to leave inflamed or infected sites, travel through the lymphatics and relocal ize to the lymph nodes [126] [127] [128] or bone marrow 109 to affect host defence. These neutrophils can shuttle live pathogens to lymph nodes 127 and modulate lymphocyte proliferation 109, 126 . Neutrophil migration from inflamed skin to lymph nodes depends on CD11b and CXCR4, and CD11b deficiency in neutrophils decreases T cell proliferation in draining lymph nodes 126 . The transport of antigen from intradermally injected modified vaccinia Ankara virus to the bone marrow by neutrophils can also initiate the expansion of viral-targeting memory CD8 + T cells 109 . Much more work needs to be done to further clarify the phenotype and the fate of reverse-migrated neutrophils and the implications for human disease.
Neutrophil migration: a drug target
The failure to appropriately resolve inflammation can have disastrous effects. Excessive and persistent infiltration of neutrophils into tissues has a role in several inflammatory diseases, including rheumatoid arthritis 129 , pulmonary fibrosis 130 and multiple organ failure 124 ; neutrophil behaviour is therefore a potential target for drug therapies. One concern regarding anti-inflammatory therapies is achieving the resolution of inflammation at a specific site without causing systemic immunosuppression. Another major goal is the identification of molecular targets that distinguish infection from wound-induced inflammation so as to not impair the ability of the body to fight invading pathogens. Drugs that induce neutrophil apoptosis or necrosis at an injury site would reduce neutrophil numbers, but the clearance of dead cells might increase overall local inflammation. Therefore, both neutrophil forward and reverse migration are attractive targets for anti-inflammatory therapies. We discuss exciting new targets in these pathways below and highlight drugs that are in the clinical trial pipeline in TABLE 1.
Targeting forward migration. To inhibit neutrophil migration to a site of damage, the neutrophil motility machinery, primary signals that recruit neutrophils or the amplification stage of inflammation could be targeted. Colchicine, a microtubule inhibitor, is a known inhibitor of neutrophil chemotaxis and impairs neutrophil recruitment to sites of inflammation in vivo. It is used to treat human conditions including gout, chronic pericarditis and familial Mediterranean fever 131 . To target neutrophil recruitment signals, the early phase of signalling may be more promising as the amplification phase involves the activation of multiple complex pathways. Conversely, inhibiting specific pathways in the amplification phase could fine-tune the neutrophil response without completely eliminating it. Several clinical trials are currently assessing the effect of CXCR1 and CXCR2 antagonists and inhibitors (TABLE 1) on inflammatory conditions ranging from cancer to autoimmune diseases (ClinicalTrials.gov), and some have reported promising results 132, 133 . However, chemokine receptor antagonist therapy has failed in the past because of differences between animal models and human patients and redundancy of the targets 134 . Other clinical trials are targeting lipid mediator-induced inflammation with LTB 4 R antagonists. Resolvins are an exciting class of molecules as they can inhibit neutro phil transmigration in vitro 135 , and two different resolvin molecules, including chemically synthesized molecules, can significantly decrease the number of neutrophils at a site of damage at least partially through decreased levels of neutrophil chemokines including CXCL1 and LTB 4 (REFS 135,136).
Targeting reverse migration. An alternative approach to decrease chronic inflammation is to promote neutrophil reverse migration from local sites of damage. Resolvins and protectins may also resolve inflammation by promoting the removal of leukocytes from injured tissue sites 137 . A drug screen in zebrafish revealed a novel drug known as tanshinone IIA, which is derived from a Chinese medicinal herb and seems to accelerate apoptosis of neutrophils and promote their reverse . However, targeting this mechanism raises several concerns, including the fate and activation state of reverse-migrated neutrophils. Disseminated neutrophils showing a strong pro-inflammatory or antiinflammatory phenotype could have deleterious effects such as promoting distal organ damage or systemic immunosuppression, respectively. A better characterization of reverse-migrated neutrophils in vivo is necessary before further advances in the development of therapies that target this mechanism.
Future perspectives
Remarkable progress has been made in the past decade in understanding the mechanisms that regulate neutrophil migration, including the cells and the signals that attract neutrophils to sites of either tissue injury or infection. However, neutrophil reverse migration remains an understudied phenomenon and future work should focus on several key questions to drive the development of new therapies for neutrophil inflammatory disorders. First, the question of whether neutrophil reverse migration is 'good' or 'bad' for inflammation outcome is still mainly unanswered. Although excessive and prolonged neutrophil infiltration can lead to the development of chronic tissue inflammation, the migration of neutrophils back into the circulation might cause systemic inflammation and tissue damage at distal organs. It is likely that the answer to this question depends on the nature, the magnitude and the location of the inflammation. In the case of infection, premature neutrophil reverse migration could lead to failure to clear the infection and to dissemination of intracellular pathogens to other sites. In the case of tissue injury, reverse migration might have positive effects at the local site of inflammation, as the depletion of neutrophils can improve wound healing 138, 139 , but may have negative effects systemically such as multiple organ failure. Another issue is the diversity of neutrophil pheno types
. In cancer models, it has been proposed that, similarly to macrophages, neutrophil phenotypes can exist on a spectrum ranging from pro-inflammatory, anti-tumour 'N1' neutrophils to anti-inflammatory, pro-tumour 'N2' neutrophils. Does a similar plasticity exist at sites of tissue damage or infection? Does the phenotype of the neutrophil have any role in its ability to stay at the injury site or to reverse migrate away? In cases of chronic inflammation, is it possible to specifically promote the reverse migration of N1 neutro phils and to leave pro-resolving N2 neutrophils at the wound? Or is it the reverse migration specifically of these N1 neutrophils that can cause systemic inflammation and distal organ damage? Does the outcome of an injury reprogramme reverse-migrating neutrophils to relay specific messages to different locations in the body? Although many unanswered questions remain, it is clear that neutrophil migration has a crucial role in inflammatory pathology. Fortunately, recent models and technologies have been developed that will enable the further elucidation of forward migration signals and the role of reverse migration in the pathophysiology of inflammatory diseases.
